Comparison of the Novel Angiotensin II Receptor Blocker Azilsartan Medoxomil vs Valsartan by Ambulatory Blood Pressure Monitoring

J Clin Hypertens (Greenwich). 2011;13:467–472. ©2011 Wiley Periodicals, Inc. Azilsartan medoxomil (AZL‐M) is a unique angiotensin II receptor blocker (ARB) under development for the treatment of hypertension. To compare this ARB with another in the class, the authors studied the effects of AZL‐M and...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Hypertens (Greenwich)
Hlavní autoři: Sica, Domenic, White, William B., Weber, Michael A., Bakris, George L., Perez, Alfonso, Cao, Charlie, Handley, Alison, Kupfer, Stuart
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Publishing Ltd 2011
Témata:
Original Papers
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8108745/
https://ncbi.nlm.nih.gov/pubmed/21762358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1751-7176.2011.00482.x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky